Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer

Background: 5-Methylcytidine (m5C) is the most common RNA modification and plays an important role in multiple tumors including cervical cancer (CC). We aimed to develop a novel gene signature by identifying m5C modification subtypes of CC to better predict the prognosis of patients. Methods: We obt...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jing, Liang, Lei-Lei, Liu, Jing, Liu, Ting-Ting, Li, Jian, Xiu, Lin, Zeng, Jia, Wang, Tian-Tian, Wang, Di, Liang, Li-Jun, Xie, Da-Wei, Chen, Ding-Xiong, An, Ju-Sheng, Wu, Ling-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493221/
https://www.ncbi.nlm.nih.gov/pubmed/34630524
http://dx.doi.org/10.3389/fgene.2021.733715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493221/
https://www.ncbi.nlm.nih.gov/pubmed/34630524
http://dx.doi.org/10.3389/fgene.2021.733715

Ejemplares similares